Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Biomarker expression correlates with 80% recurrence rate in retrospective study
December 30th, 2004
TriPath Imaging, Inc. (Nasdaq: TPTH) announced that data generated from in-house studies of the company's proprietary breast cancer biomarkers demonstrate a strong correlation between biomarker expression and recurrence of breast cancer in archived breast tissue samples from a retrospective cohort of patients with early stage breast cancer. The results of in-house research and case studies prepared by an independent investigator were presented December 8, 2004, at the 27th Annual San Antonio Breast Cancer Symposium and at a TriPath Imaging-sponsored symposium held in San Antonio. The results of in-house studies were based on analysis of 427 archived...
Source: Women's Health Weekly (2004-12-30)
|
